Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews

No studies found 2 · 40%GRADE not reported 0 · 0%Very low 1 · 20%Low 0 · 0%Moderate 2 · 40%High 0 · 0%

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Renal replacement therapy

The review found no eligible studies for this question.

1 finding from 1 review

Colloids versus crystalloids for fluid resuscitation in critically ill people 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adverse events

The review found no eligible studies for this question.

1 finding from 1 review

Colloids versus crystalloids for fluid resuscitation in critically ill people 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

All‐cause mortality (at end of

Dextrans showed no clear difference in all‐cause mortality (at end of compared with crystalloid (moderate certainty).

1 finding from 1 review

Colloids versus crystalloids for fluid resuscitation in critically ill people 2018 · Cochrane Headline outcomes only
RR 0.99 [0.88, 1.11]
19 studies · 4736 participants
Moderate

All‐cause mortality (within 90 days and within 30 days)

Dextrans showed no clear difference in all‐cause mortality (within 90 days and within 30 days) compared with crystalloid (moderate certainty).

1 finding from 1 review

Colloids versus crystalloids for fluid resuscitation in critically ill people 2018 · Cochrane Headline outcomes only
RR 0.99 [0.87, 1.12]
10 studies · 3353 participants
Moderate

Transfusion of blood products

It is very uncertain whether dextrans changes transfusion of blood products compared with crystalloid (very low certainty).

1 finding from 1 review

Colloids versus crystalloids for fluid resuscitation in critically ill people 2018 · Cochrane Headline outcomes only
RR 0.92 [0.77, 1.1]
3 studies · 1272 participants
Very low